Novel Inflammatory Indices in Aortic Disease.

Area of Science:

• Cardiovascular Medicine
• Immunology
• Pathophysiology

Background:

• Inflammation is a critical factor in atherosclerosis, influencing endothelial dysfunction and plaque development.
• The role of inflammation in other cardiovascular diseases, particularly aortic diseases, requires further investigation.
• Aortic valve stenosis and aortic aneurysms are linked to inflammation and carry high morbidity and mortality rates.

Purpose of the Study:

• To highlight the importance of inflammation in aortic diseases.
• To emphasize the need for easily measurable inflammatory biomarkers for aortic diseases.
• To facilitate the understanding of molecular and cellular mechanisms underlying aortic disease development.

Main Methods:

• Review of existing literature on inflammation in cardiovascular diseases.
• Analysis of the role of inflammatory processes in the pathogenesis of aortic valve stenosis and aortic aneurysms.
• Discussion on the potential of inflammatory biomarkers for early diagnosis and risk stratification.

Main Results:

• Inflammation is integral to the development and progression of atherosclerosis and aortic diseases.
• Current biomarkers for aortic diseases with prognostic value for survival are limited.
• Identifying specific inflammatory markers could improve early detection and risk assessment.

Conclusions:

• Inflammation is a fundamental component of aortic diseases, including aortic valve stenosis and aneurysms.
• There is a critical need for novel, easily measurable biomarkers to assess inflammation in aortic diseases.
• Understanding inflammatory mechanisms can provide a pathophysiological basis for early diagnosis and improved patient outcomes.